Correlation Between Evoke Pharma and Petros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Petros Pharmaceuticals, you can compare the effects of market volatilities on Evoke Pharma and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Petros Pharmaceuticals.
Diversification Opportunities for Evoke Pharma and Petros Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Evoke and Petros is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Petros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Evoke Pharma and Petros Pharmaceuticals
Given the investment horizon of 90 days Evoke Pharma is expected to under-perform the Petros Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Evoke Pharma is 2.86 times less risky than Petros Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Petros Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 365.00 in Petros Pharmaceuticals on August 24, 2024 and sell it today you would lose (338.00) from holding Petros Pharmaceuticals or give up 92.6% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Evoke Pharma vs. Petros Pharmaceuticals
Performance |
Timeline |
Evoke Pharma |
Petros Pharmaceuticals |
Evoke Pharma and Petros Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evoke Pharma and Petros Pharmaceuticals
The main advantage of trading using opposite Evoke Pharma and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
Petros Pharmaceuticals vs. Sunshine Biopharma | Petros Pharmaceuticals vs. Sonoma Pharmaceuticals | Petros Pharmaceuticals vs. Alpha Teknova | Petros Pharmaceuticals vs. Evoke Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |